Approval · Notice of Compliance 17685 · 2016
COPAXONE: Notice of Compliance 17685
Issued January 19, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17685
- Date
- January 19, 2016
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COPAXONE | 02245619 | Marketed |
Medicinal ingredients
- GLATIRAMER ACETATE 20 MG per 1ML